schliessen

Filtern

 

Bibliotheken

3.

Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytoma.
by Bid, Hemant K

Clinical cancer research : an official journal of the American Association for Cancer Research, December 15, 2013, Vol.19(24), pp.6716-6729

123

Recommended databases

Find more Articles matching your search terms in these recommended databases.

Filter electronic articles 50 Hits

Remove Filters